Zacks Research Brokers Decrease Earnings Estimates for CPRX
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Catalyst Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will earn $2.02 per share for the year, […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Catalyst Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will earn $2.02 per share for the year, […]
